Johnson & Johnson incurred an acquired in-process research and development expense of approximately $1.0 billion related to the acquisition of Firefly Bio, Inc. in fiscal 2026.
Quarterly report (Form 10-Q)
Filing excerpt
The fiscal third quarter and nine months of 2026 includes a charge of approximately $5.5 billion related to the proposed talc ovarian litigation resolution and $1.0 billion of acquired in-process research and development expense related to the acquisition of Firefly Bio, Inc.
What this signalsIntegration work after a deal often opens needs for new systems and services.
sec-10qacquisitionCompletedGet every 10-Q signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/977f19e5-8d66-4176-a55f-33a95d3c9004 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "977f19e5-8d66-4176-a55f-33a95d3c9004",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-10-27T08:04:15.055+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "Johnson & Johnson incurred an acquired in-process research and development expense of approximately $1.0 billion related to the acquisition of Firefly Bio, Inc. in fiscal 2026. Sellers of oncology pipeline integration and lab informatics tools may find integration opportunities.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "acquired in-process research and development expense related to the acquisition of Firefly Bio, Inc.",
"dollar_millions": 1000
},
"quarter": "Q3",
"summary": "J&J records $1.0 billion IPR&D charge for Firefly Bio acquisition",
"excerpts": "The fiscal third quarter and nine months of 2026 includes a charge of approximately $5.5 billion related to the proposed talc ovarian litigation resolution and $1.0 billion of acquired in-process research and development expense related to the acquisition of Firefly Bio, Inc.",
"relevance": 0.8,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/jnj-20260927.htm",
"filing_date": "2026-10-21",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "09/27",
"period_end_date": "2026-09-27",
"sales_relevance": "Active integration needs",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/977f19e5-8d66-4176-a55f-33a95d3c9004 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.